About Maxonis

The Maxonis team is a group of leading experts, driven by a shared mission to advance groundbreaking solutions for  nerve repair.

Founding Team

Experienced operators in nerve repair, biomaterials, and biotech commercialization
Itay Itzhaky
Co-Founder & CEO

Health-tech executive with > $270M in exits (ColBar → J&J, Datum Dental → Dentsply). Expertise in scaling regenerative products, regulatory strategy, and commercialization.

Prof. Shimon Rochkind, MD, PhD
Co-Founder & CMO

World leader in nerve regeneration & microsurgery. Former Head of Peripheral Nerve Reconstruction at TLV Medical Center and Tel-Aviv University. 80+ publications.

Dr. Arie Goldlust PhD
Co-Founder & CTO

Biochemist & biomaterials innovator; co-founded Datum Dental (acquired by Dentsply). Deep experience in formulation, CMC, and regenerative product development.

Maxonis Team

Driven operators building the future of nerve regeneration.
Dr. Lilach Weisz, PhD
VP BD

Strategic Partnerships and Growth

Dr. Mara Almog, PhD
R&D Director

R&D, preclinical development and publication

Yafit Keret
CFO

Finance, fund raising and investors relation 

Elia Spector
VP of People & Partner Engagement

Asher Kachlon
R&D Manager

R&D, product development & formulations 

Dr. Yael Nadel, PhD
Analytics Manager

Analytical development, testing, QC

Scientific & Clinical Advisory Board

Global experts in neurosurgery, nerve repair, biomaterials, and translational science.
Dr. Jim Schuster MD, PhD
Professor of Neurosurgery Sarcoma Program Team Member Director of Neuro-Trauma Director of Education University of Pennsylvania

Professor  Eric L. Zager, MD
Neurosurgery Perelman School of Medicine University of Pennsylvania Philadelphia, PA

Prof. Dr. Thomas Kretschmer, MD
IFAANS, FEBNS Neurosurgeon,  PhD,

Jim Martucci, MSc.
Medical Device Technology Consultant

"Maxonis was founded with a mission to bring hope and relief to people whose life quality was severely affected by brain & nerve trauma.”

Photo of Maxonis CEO Itay Itzhaky

Itay Itzhaky

Maxonis CEO

Text Link